Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Hypertension peptide trials
6 selected ClinicalTrials.gov records carrying the official condition label Hypertension. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
6 selected records.
4 profiles.
2015–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 128 selected PubMed records and 78 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Hypertension unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT00223717
PeptideScanner retained ClinicalTrials.gov record NCT00223717 at 2026-11-16T01:33:21.554Z. Its registry update date was 2017-10-13, and PeptideScanner's reviewed identity mapping was desmopressin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- October 13, 2017
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01413542
PeptideScanner retained ClinicalTrials.gov record NCT01413542 at 2026-11-16T01:39:41.882Z. Its registry update date was 2015-11-04, and PeptideScanner's reviewed identity mapping was nesiritide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- November 4, 2015
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01977859
PeptideScanner retained ClinicalTrials.gov record NCT01977859 at 2026-11-16T01:39:41.882Z. Its registry update date was 2018-02-14, and PeptideScanner's reviewed identity mapping was nesiritide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- February 14, 2018
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Leuprolide · 2026-11-02
ClinicalTrials.gov record NCT07848828
Recruiting at the retained observation.
Open attributed record →Bivalirudin · 2026-08-21
ClinicalTrials.gov record NCT04278404
Recruiting at the retained observation.
Open attributed record →Nesiritide · 2018-02-14
ClinicalTrials.gov record NCT01977859
Completed at the retained observation.
Open attributed record →Nesiritide · 2018-01-03
ClinicalTrials.gov record NCT02608996
Recruiting at the retained observation.
Open attributed record →Desmopressin · 2017-10-13
ClinicalTrials.gov record NCT00223717
Completed at the retained observation.
Open attributed record →Nesiritide · 2015-11-04
ClinicalTrials.gov record NCT01413542
Completed at the retained observation.
Open attributed record →